162 related articles for article (PubMed ID: 8455938)
1. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
Kohlhuber F; Strobl LJ; Eick D
Oncogene; 1993 Apr; 8(4):1099-102. PubMed ID: 8455938
[TBL] [Abstract][Full Text] [Related]
2. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
3. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
Eick D; Polack A; Kofler E; Bornkamm GW
Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949
[TBL] [Abstract][Full Text] [Related]
4. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells.
Sasaki H; Watanabe T; Nomura S; Oishi M
Jpn J Cancer Res; 1987 Aug; 78(8):776-9. PubMed ID: 3115922
[TBL] [Abstract][Full Text] [Related]
5. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of a c-myc mRNA initiated in intron 1 with the normal c-myc mRNA and similar regulation of both transcripts in mammalian cells.
Ray D; Robert-Lézénès J
Oncogene Res; 1989; 5(1):73-8. PubMed ID: 2674860
[TBL] [Abstract][Full Text] [Related]
7. Effects of IL-3 on promoter usage, attenuation and antisense transcription of the c-myc oncogene in the IL-3-dependent Ba/F3 early pre-B cell line.
Chang Y; Spicer DB; Sonenshein GE
Oncogene; 1991 Nov; 6(11):1979-82. PubMed ID: 1682864
[TBL] [Abstract][Full Text] [Related]
8. In vivo footprints between the murine c-myc P1 and P2 promoters.
Plet A; Tourkine N; Mechti N; Jeanteur P; Blanchard JM
Oncogene; 1992 Sep; 7(9):1847-51. PubMed ID: 1501892
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
10. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
Prochownik EV; Kukowska J
Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
[TBL] [Abstract][Full Text] [Related]
11. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation.
Kirsch IR; Bertness V; Silver J; Hollis GF
J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612
[TBL] [Abstract][Full Text] [Related]
12. Changes in promoter utilization in human and mouse c-myc genes upon transformation induction in temperature-sensitive cell lines.
Luo Y; Krause MO
J Cell Physiol; 1994 Aug; 160(2):303-15. PubMed ID: 8040189
[TBL] [Abstract][Full Text] [Related]
13. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S
Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109
[TBL] [Abstract][Full Text] [Related]
14. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
[TBL] [Abstract][Full Text] [Related]
15. Changes in in vivo protein-DNA interactions occur at the c-myc P2 promoter during differentiation.
Bryans M; Lang JC; Wilkie NM
Biochem Biophys Res Commun; 1993 Dec; 197(3):1363-9. PubMed ID: 8280153
[TBL] [Abstract][Full Text] [Related]
16. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
Darling D; Tavassoli M; Linskens MH; Farzaneh F
Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
[TBL] [Abstract][Full Text] [Related]
17. Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell line.
Francastel C; Groisman R; Pfarr CM; Robert-Lézénès J
Oncogene; 1994 Jul; 9(7):1957-64. PubMed ID: 8208542
[TBL] [Abstract][Full Text] [Related]
18. Regulation of murine Max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells.
Dunn BK; Cogliati T; Cultraro CM; Bar-Ner M; Segal S
Cell Growth Differ; 1994 Aug; 5(8):847-54. PubMed ID: 7986749
[TBL] [Abstract][Full Text] [Related]
19. Elongation and premature termination of transcripts initiated from c-fos and c-myc promoters show dissimilar patterns.
Plet A; Eick D; Blanchard JM
Oncogene; 1995 Jan; 10(2):319-28. PubMed ID: 7838531
[TBL] [Abstract][Full Text] [Related]
20. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]